An autologous bone marrow transplant is a treatment in which your own blood-forming stem cells are collected, frozen, and later given back to you after high-dose chemotherapy. The stem cells act as a rescue: they allow doctors to use doses of chemotherapy strong enough to destroy cancer cells, then rebuild your marrow afterward. It is most often used for multiple myeloma and certain lymphomas.
Because the cells come from your own body, there is no donor matching and no risk of graft-versus-host disease. This guide explains who benefits, what each step involves, and what recovery looks like.
What Is an Autologous Transplant?
“Autologous” means “from the same person.” Your hematopoietic stem cells, the parent cells that produce red cells, white cells, and platelets, are harvested before treatment. You then receive high-dose chemotherapy, sometimes called conditioning, which wipes out cancer cells but also destroys healthy bone marrow tissue. The stored stem cells are then returned through a drip, travel to the marrow, and restart blood production.
Despite the name, most autologous transplants today use peripheral blood stem cells collected from the bloodstream rather than marrow taken directly from the hip bone. Collection from blood is less invasive and tends to give faster recovery of counts. The term “bone marrow transplant” has stuck because the cells are the same ones that live in the bone marrow.
Who Is It For?
Autologous transplant works mainly by allowing higher doses of chemotherapy, not by bringing in a new immune system. It therefore suits cancers that are highly sensitive to chemotherapy. Common indications among hematological conditions include:
- Multiple myeloma, where it is a standard part of first-line treatment for eligible patients.
- Relapsed Hodgkin lymphoma and aggressive non-Hodgkin lymphomas that still respond to chemotherapy.
- Selected other lymphomas, such as mantle cell lymphoma in some treatment pathways.
- AL amyloidosis and certain germ cell tumors in carefully chosen patients.
- Selected autoimmune diseases, such as some cases of multiple sclerosis, in specialist centers.
It is used less for acute leukemias, where the donor immune effect of an allogeneic transplant is usually needed.
| Feature | Autologous transplant | Allogeneic transplant |
|---|---|---|
| Source of stem cells | The patient | A matched or partly matched donor |
| Donor search needed | No | Yes |
| Graft-versus-host disease | Does not occur | A major risk |
| Graft-versus-tumor effect | None | Present and often important |
| Main risk of failure | Disease relapse | Transplant complications and relapse |
| Typical uses | Myeloma, lymphoma | Acute leukemias, MDS, marrow failure |
Step by Step: How the Transplant Works
- Assessment: blood tests, heart and lung function tests, imaging, and often a bone marrow biopsy and bone marrow aspirate to check disease status and overall fitness.
- Mobilization: injections of granulocyte colony-stimulating factor (G-CSF), sometimes with chemotherapy or the drug plerixafor, push stem cells out of the marrow into the blood.
- Collection (apheresis): blood is drawn through a line, a machine separates out the stem cells, and the rest is returned. Collections are measured by counting CD34+ cells; a commonly used minimum is about 2 million CD34+ cells per kilogram of body weight for one transplant.
- Freezing: the cells are cryopreserved and stored until needed.
- Conditioning: high-dose chemotherapy is given over one to several days. High-dose melphalan is standard for myeloma; combination regimens such as BEAM are common for lymphoma.
- Reinfusion (day 0): the thawed cells are given through a central line, much like a blood transfusion.
- Engraftment: the new cells settle in the marrow and begin producing blood. Neutrophils typically recover within about two weeks.
Risks and Side Effects
Even without a donor, an autologous transplant is intensive. The main risks come from the high-dose chemotherapy and the period before the new cells engraft:
- Infection while white cells are very low, which is why fever is treated urgently with antibiotics.
- Bleeding and anemia, managed with platelet and red cell transfusions.
- Mucositis, painful inflammation of the mouth and gut, along with nausea, diarrhea, and poor appetite.
- Fatigue that can last weeks to months.
- Late effects such as reduced fertility and a small risk of secondary blood cancers, including myelodysplastic syndrome.
- Relapse of the original disease, which is the main reason autologous transplants fail.
Rarely, not enough stem cells can be collected. In that case, the team may try another mobilization strategy or consider alternative treatments.
Recovery and Follow-Up
Most patients stay in hospital, or attend daily as outpatients in some centers, for around two to four weeks until counts recover and eating and drinking are adequate. Energy returns gradually over the following months.
After discharge, follow-up focuses on blood counts, infection prevention, and monitoring the underlying hematologic condition. Childhood vaccinations are usually repeated, since high-dose chemotherapy erases much of the immune memory. Some patients, particularly with myeloma, go on to maintenance therapy to prolong remission. In my practice, I tell patients to think of the first three months as a recovery period rather than a return to full activity.
When to See a Doctor
After an autologous transplant, contact your transplant team immediately if you develop a temperature of 38°C (100.4°F) or higher, shivering, new bleeding or bruising, breathlessness, severe diarrhea, or inability to keep fluids down. These can be early signs of infection or other complications that are much easier to treat when caught early.
Before transplant, ask your hematologist whether autologous transplant is part of the standard pathway for your condition and how it compares with other options for other hematological disorders.
Frequently Asked Questions
Is an autologous transplant painful?
The stem cell infusion itself is not painful and feels similar to a blood transfusion. The difficult part is the side effects of high-dose chemotherapy, such as mouth sores and fatigue, which are managed with pain relief and supportive care.
How long does it take to recover from an autologous transplant?
Blood counts usually recover within a few weeks. Full energy and immune recovery often take several months, and some people need up to a year to feel completely themselves.
Can cancer come back after an autologous transplant?
Yes. Because there is no donor immune system to attack remaining cancer cells, relapse is the main risk. Maintenance therapy and regular monitoring are used to reduce and detect it.
Why use my own cells instead of a donor’s?
Your own cells avoid graft-versus-host disease and the need for a donor search, making the procedure safer. The trade-off is that there is no graft-versus-tumor effect, so it is chosen for diseases where high-dose chemotherapy is the key benefit.
